Connor, Clark & Lunn Investment Management (CC&L)
MIRM icon

Connor, Clark & Lunn Investment Management (CC&L)’s Mirum Pharmaceuticals MIRM Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2M Sell
420,063
-59,413
-12% -$5.97M 0.09% 199
2026
Q1 		$44.3M Sell
479,476
-42,176
-8% -$3.97M 0.1% 188
2025
Q4 		$41.2M Buy
521,652
+25,676
+5% +$1.84M 0.11% 165
2025
Q3 		$36.4M Buy
495,976
+72,232
+17% +$4.59M 0.11% 172
2025
Q2 		$21.6M Buy
423,744
+67,468
+19% +$3M 0.08% 234
2025
Q1 		$16.1M Buy
356,276
+179,316
+101% +$8.45M 0.07% 230
2024
Q4 		$7.32M Buy
176,960
+109,585
+163% +$4.57M 0.03% 388
2024
Q3 		$2.63M Buy
67,375
+21,526
+47% +$859K 0.01% 605
2024
Q2 		$1.57M Buy
+45,849
New +$1.2M 0.01% 725
2024
Q1 		– Sell
-133,527
Closed -$3.94M – 1645
2023
Q4 		$3.94M Buy
133,527
+19,418
+17% +$588K 0.02% 495
2023
Q3 		$3.61M Buy
114,109
+76,369
+202% +$2.09M 0.02% 478
2023
Q2 		$976K Buy
+37,740
New +$1M ﹤0.01% 801
2022
Q4 		– Sell
-10,689
Closed -$225K – 1351
2022
Q3 		$225K Sell
10,689
-3,784
-26% -$91.1K ﹤0.01% 975
2022
Q2 		$282K Sell
14,473
-8,534
-37% -$201K ﹤0.01% 872
2022
Q1 		$507K Sell
23,007
-2,611
-10% -$53.3K ﹤0.01% 782
2021
Q4 		$409K Buy
+25,618
New +$399K ﹤0.01% 836

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MIRM Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Mirum Pharmaceuticals (MIRM) stake by 12% in Q2 2026, selling an estimated $5.97M and leaving 420,063 shares worth $49.2M. The position accounts for 0.09% of the portfolio, ranked #199.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MIRM in Q4 2021 and has held it in 16 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 420,063 shares of Mirum Pharmaceuticals worth $49.2M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 59,413 Mirum Pharmaceuticals shares in Q2 2026, an estimated $5.97M.
  • Mirum Pharmaceuticals made up 0.09% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #199 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Mirum Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.